Donate
Join Us

Clinical Trials

First Pediatric Patient Dosed in Taysha US Clinical Trial
January 10, 2024
First Pediatric Patient Dosed in Taysha US Clinical Trial
Taysha Gene Therapies reports on safety and efficacy results for the first patient to receive gene therapy for Rett Syndrome
December 27, 2023
Taysha Pediatric Gene Therapy Trial Is Open for Enrollment in US
Neurogene doses first two children in gene therapy trial
November 30, 2023
Neurogene Doses First Two Patients in Pediatric US Trial
Taysha Gene Therapies reports on safety and efficacy results for the first patient to receive gene therapy for Rett Syndrome
November 29, 2023
Taysha Expands Age Eligibility for Canadian Clinical Trial
news_article_-_taysha_1
July 31, 2023
Taysha Cleared to Dose Second Patient in Gene Therapy Trial
neurogene_mailchimp_banner_1200_x_700_px_3
June 12, 2023
Details on Neurogene Gene Therapy Trial Now on ClinicalTrial.gov
neurogene_website_banner_1500x700
April 18, 2023
Neurogene Shares Key Information on Gene Therapy Clinical Trial with the Rett Community
copy_of_news-researcher-_blue_r
March 3, 2023
What Wearables and AI Can Tell Us About Rett Syndrome Severity
hero-taysha-gene-therapies-shares-letter-to-the-rett-syndrome-community-1
February 1, 2023
Taysha Provides Update For Their Rett Syndrome Gene Replacement Program
neurogene-2023-news-banner
January 23, 2023
Neurogene Receives FDA Approval for Gene Replacement Clinical Trial for Rett Syndrome
mini-mecp2-banner
January 10, 2023
The Story Behind Mini-MeCP2
2022-accomplishments-newsbanner
December 19, 2022
What We Accomplished in 2022
company_update_-_hero_for_blog_1
December 13, 2022
What We Learned from Taysha’s Clinical Trial Community Update
hero-taysha-gene-therapies-shares-letter-to-the-rett-syndrome-community-1
October 26, 2022
Taysha Gene Therapies Shares Rett Syndrome Community Statement on its Collaboration with Astellas Gene Therapies
hero-taysha-gene-therapies-shares-letter-to-the-rett-syndrome-community-1
October 25, 2022
Taysha Announces Collaboration with Astellas Gene Therapies
hero-taysha-gene-therapies-shares-letter-to-the-rett-syndrome-community-1
March 30, 2022
Taysha Gene Therapies Shares Rett Syndrome Community Statement on its Clinical Trial
hero-many-ways-to-participate-in-fda
March 4, 2022
Many ways to participate in the public meeting with the FDA on March 11
hero-outcomes-of-a-marathon-fda-meeting-on-the-safety-of-gene-replacement
September 28, 2021
Outcomes of a Marathon FDA Meeting on the Safety of Gene Replacement
$40M
Take Action